US2019177726A1PendingUtilityA1
Method of regulating gene expression
Est. expiryMay 3, 2022(expired)· nominal 20-yr term from priority
C12N 15/113C12N 15/8241C12N 2310/111C12N 2310/14C12N 2310/531C12N 15/8218C12N 15/111C12N 2310/141C07H 21/04C12N 2310/53C12N 2330/30
73
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates, in general, to gene expression and, in particular, to a method of inhibiting the expression of a target gene and to constructs suitable for use in such a method.
Claims
exact text as granted — not AI-modified1 .- 30 . (canceled)
31 . A DNA construct comprising a polymerase II-based promoter functional in said cell operably linked to a nucleic acid comprising a nucleotide sequence encoding, as part of a longer encoded sequence, an miRNA precursor, said miRNA precursor comprising a stem loop structure and comprising in said stem of said stem loop structure a sequence complementary to a portion of an RNA transcript of a target gene, wherein said stem of said stem loop structure is about 19-45 base pairs long and the loop of said stem loop structure is about 4-25 nucleotides.
32 . The DNA construct according to claim 31 , wherein said loop of said stem loop structure of said miRNA precursor comprises a sequence corresponding to a naturally occurring miRNA.
33 . The DNA construct according to claim 31 , wherein the base of said stem of said stem loop structure of said miRNA precursor comprises a base paired region at least 3 base pairs in length.
34 . The DNA construct according to claim 31 , wherein said stem of said stem loop structure of said miRNA precursor includes at least one bulge.
35 . The DNA construct of claim 34 , wherein the bulge is not present within the last three base pairs at the base of said stem.
36 . The DNA construct according to claim 31 , wherein said construct is present in a viral vector.
37 . The DNA construct according to claim 31 , wherein said construct is present in a plasmid.
38 . The DNA construct according to claim 31 , wherein said loop of said stem loop structure of said miRNA precursor comprises 6-15 nucleotides.
39 . The DNA construct according to claim 31 , wherein the polymerase II-based promoter is a constitutive promoter.
40 . The DNA construct according to claim 31 , wherein the polymerase II-based promoter is an inducible promoter.
41 . The DNA construct according to claim 31 , wherein the polymerase II-based promoter is a tissue-specific promoter.Join the waitlist — get patent alerts
Track US2019177726A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.